Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute, — Detroit, Michigan

Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute, is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute, has participated in 1 clinical trials.

Therapeutic areas: Classical Hodgkin Lymphoma.

Sponsors: Rhizen Pharmaceuticals SA.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute,?

Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute, has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute, conducted?

Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute, has 1 clinical trials on record. Their work covers Classical Hodgkin Lymphoma.

Is Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute, accredited by Crixeo Health?

Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhizen Pharmaceuticals investigational trial site; Karmanos Cancer Institute,?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.